Literature DB >> 23838095

Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field.

Evan Shereck1, Shalini Shenoy, Michael Pulsipher, Linda Burns, Arthur Bracey, Jeffrey Chell, Edward Snyder, Eneida Nemecek.   

Abstract

The National Marrow Donor Program (NMDP) projects the need for allogeneic unrelated blood and marrow transplantation (BMT) in the United States as 10,000 per year. Although the NMDP is preparing to facilitate that number by the year 2015, there are several barriers to meeting this goal, including the need to recruit more health care personnel, including BMT physicians. To learn how best to recruit BMT physicians, we examined why practicing BMT physicians chose to enter the field and why others did not. We conducted a Web-based survey among pediatric hematology/oncology (PHO) and BMT physician providers and trainees to identify the factors influencing their decision to choose or not choose a career in BMT. Out of 259 respondents (48% male, 74% of Caucasian origin), 94 self-identified as BMT physicians, 112 as PHO physicians, and 53 as PHO trainees. The PHO and BMT providers spent an average of 53% of their time in clinical activities. More than two-thirds of PHO providers reported providing BMT services at their institutions, most commonly for inpatient coverage (73%). The proportion of providers exposed to BMT early in training was significantly higher among BMT providers compared with PHO providers (51% versus 18% in medical school [P < .0001]; 70% versus 50% during residency [P < .005]). Exposure during fellowship (94%) did not differ between the 2 groups. The decision to pursue a career in BMT was made before fellowship (medical school or residency) by 50% of the respondents. A lower proportion of BMT providers than PHO providers reported current involvement in the education of medical students and residents (76% versus 98%; P < .0001). Of the 53 trainees who responded, 64% reported not contemplating a career in BMT. Of these, 68% identified inadequate exposure to BMT before PHO fellowship as the reason behind this decision. Only 26% reported receiving exposure to the BMT field while in medical school, and 43% reported exposure during residency. The 2 most common reasons cited for choosing a career as a BMT physician were the degree of intellectual and scientific challenge (89%) and the influence of role models/mentors in the field (67%). The results of this survey suggest that early exposure to BMT during medical school and residency is associated with increased interest in pursuing a career in BMT. BMT physicians and training program directors can foster interest in the field by promoting BMT-focused education and clinical inpatient and outpatient rotations during medical school and residency. This early exposure to BMT may aid recruitment of future transplantation providers.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow transplantation; Pediatric; Physician capacity; Recruitment; Workforce

Mesh:

Year:  2013        PMID: 23838095      PMCID: PMC4870047          DOI: 10.1016/j.bbmt.2013.06.021

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  6 in total

1.  Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Authors:  Naynesh R Kamani; Mark C Walters; Shelly Carter; Victor Aquino; Joel A Brochstein; Sonali Chaudhury; Mary Eapen; Brian M Freed; Michael Grimley; John E Levine; Brent Logan; Theodore Moore; Julie Panepinto; Suhag Parikh; Michael A Pulsipher; Jane Sande; Kirk R Schultz; Stephen Spellman; Shalini Shenoy
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-16       Impact factor: 5.742

Review 2.  Allogeneic transplant physician and center capacity in the United States.

Authors:  Navneet S Majhail; Elizabeth A Murphy; Nancy A Omondi; Pam Robinett; James L Gajewski; C Fred LeMaistre; Dennis Confer; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

3.  The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment.

Authors:  Navneet S Majhail; Elizabeth A Murphy; Ellen M Denzen; Stacy Stickney Ferguson; Stacy S Ferguson; Claudio Anasetti; Arthur Bracey; Linda Burns; Richard Champlin; Norman Hubbard; Miriam Markowitz; Richard T Maziarz; Erin Medoff; Joyce Neumann; Kim Schmit-Pokorny; Daniel J Weisdorf; Deborah S Yolin Raley; Jeffrey Chell; Edward L Snyder
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-14       Impact factor: 5.742

4.  Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.

Authors:  Alana A Kennedy-Nasser; Kathryn S Leung; Anita Mahajan; Heidi L Weiss; James A Arce; Stephen Gottschalk; George Carrum; Shakila P Khan; Helen E Heslop; Malcolm K Brenner; Catherine M Bollard; Robert A Krance
Journal:  Biol Blood Marrow Transplant       Date:  2006-12       Impact factor: 5.742

5.  Preparing for growth: current capacity and challenges in hematopoietic stem cell transplantation programs.

Authors:  Jeffrey R Schriber; Claudio Anasetti; Helen E Heslop; Alan K Leahigh
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-16       Impact factor: 5.742

6.  Impending challenges in the hematopoietic stem cell transplantation physician workforce.

Authors:  James L Gajewski; C Frederick LeMaistre; Samuel M Silver; Michael C Lill; George B Selby; Mary M Horowitz; J Douglas Rizzo; Helen E Heslop; Claudio Anasetti; Richard T Maziarz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-23       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.